Clinical Trials Browser

Phase 1 × Adalimumab × 1 year × Clear all

NCT07181694 2025-10-03

A Study of Pharmacokinetics, Safety, and Immunogenicity of BCD-057 100 mg/mL, BCD-057 50 mg/mL, and Humira 100 mg/mL in Healthy Subjects

Phase 1 Recruiting

Healthy Adult Male